Public Calendar: March 1-7, 2020
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs
No Significant Event
Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner
No Significant Event
Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs
No Significant Event
Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs
No Significant Event
Official Name: Jim Sigg, Deputy Commissioner for Operations
No Significant Event
Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response
No Significant Event
Official Name: Lowell Schiller, Principal Associate Commissioner for Policy
No Significant Event
Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy
No Significant Event
Official Name: Judy McMeekin, Acting Associate Commissioner for Regulatory Affairs
No Significant Event
Official Name: Laura Caliguiri, Associate Commissioner for External Affairs
No Significant Event
Official Name: RADM Denise Hinton, Chief Scientist
No Significant Event
Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research
No Significant Event
Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
Event Date: 03/02/2020
Location: San Francisco, CA
Subject: 27th International Molecular Med TRI-CON: Advancing Precision Medicine: C10: Renaissance of Gene Therapy and Genome Editing
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives from industry, academia, government, and media
Event Date: 03/03/2020
Location: Silver Spring, MD
Subject: Facilitating End-to-End Development of Individualized Therapeutics Public Workshop
FDA Participant/Group: CELIA SILVERMAN; LARISSA LAPTEVA; SANDHYA SANDUJA; REBECCA REINDEL; JULIENNE VAILLANCOURT; ROBERT SCHOOLEY; ZHENZHEN XU; ZUBEN SAUNA; GOPA RAYCHAUDHURI;
Non FDA Participant/Group: Representatives from government, academia, industry
Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health
Event Date: 03/04/2020
Location: Silver Spring, MD
Subject: Opening Remarks (Remotely): Colorado BioScience Association Medical Device Symposium
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives from various industry groups
Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition
No Significant Event
Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products
No Significant Event
Official Name: Steven Solomon, Director, Center for Veterinary Medicine
No Significant Event
Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research
No Significant Event
Official Name: Stacy Cline Amin, Chief Counsel
Event Date: 03/05/2020
Location: Silver Spring, MD
Subject: Zofran Citizen Petition
FDA Participant/Group: MEADOW PLATT; ELIZABETH JUNGMAN; JANICE WEINER; NICHOLAS BESHARA; KAREN SCHIFTER; AMANDA EDMONDS; ANNAMARIE KEMPIC; SARA BEARDSLEY;
Non FDA Participant/Group: Brennan Torregrossa, Bridget Lankford , Patrick Wier, Sabine Luik (Glaxo Smith Kline); Jennifer Hill (Shook, Hardy & Bacon LLP); Amy Saharia (Williams & Connolly LLP); Thomas Sheehan (Phillips Lytle LLP);